What lidocaine dose should be used for an adult with trochanteric hip bursitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lidocaine Dose for Hip Bursa Injection

For trochanteric hip bursitis injection in adults, use 4-5 mL of 1% lidocaine (40-50 mg total) mixed with corticosteroid, staying well below the maximum safe dose of 4.5 mg/kg (or 7.0 mg/kg with epinephrine). 1

Dosing Framework

Maximum Safe Limits (Critical Safety Parameters)

The FDA-approved maximum doses for lidocaine infiltration are 2:

  • Without epinephrine: 4.5 mg/kg (maximum 300 mg total)
  • With epinephrine: 7.0 mg/kg (maximum 500 mg total)

These limits apply to all local infiltrative procedures and provide your safety ceiling 1.

Practical Dosing for Hip Bursa Injection

Standard approach: 4-5 mL of 1% lidocaine (40-50 mg) is the most commonly used volume for trochanteric bursa injections based on clinical research 3, 4, 5, 6. This represents:

  • For a 70 kg patient: 0.57-0.71 mg/kg (well below the 4.5 mg/kg limit)
  • Provides adequate local anesthesia without approaching toxic doses
  • Allows mixing with corticosteroid in the same syringe

Volume Considerations

Research demonstrates that 5 mL total injectate volume (lidocaine plus corticosteroid) is standard practice 3, 7. One study specifically used "5 mL of 1% lidocaine and 80 mg methylprednisolone" for trochanteric bursa injection 3.

Clinical Evidence Base

Multiple studies support this dosing range:

  • 4 mL of 1% lidocaine mixed with betamethasone showed 77% improvement at 1 week 4
  • 2% lidocaine (volume not specified) with corticosteroid achieved 49% success with injection alone 5
  • 1% lidocaine mixed with glucocorticoids provided long-term symptom relief 6

The 2021 survey of sports medicine physicians found that 79-87% use lidocaine (not ropivacaine) for large joint and bursa injections, with 5-7 mL total injectate volume being most common 7.

Safety Considerations

Always calculate maximum allowable dose before injection 1:

  • For 70 kg patient without epinephrine: 315 mg maximum (31.5 mL of 1%)
  • For 70 kg patient with epinephrine: 490 mg maximum (49 mL of 1%)

Your 4-5 mL dose represents only 13-16% of the maximum safe dose, providing an excellent safety margin.

Key safety steps 1:

  • Aspirate before injection to avoid intravascular administration
  • Use incremental injection technique
  • Monitor for early signs of toxicity (circumoral numbness, metallic taste, tinnitus)
  • Use lowest effective concentration and dose

Technical Points

Needle length matters: Use at least a 2-inch (50.8 mm) needle to consistently reach the trochanteric bursa 3. Shorter needles may result in subcutaneous rather than bursal injection.

Concentration choice: While both 1% and 2% lidocaine are used 5, 8, 1% lidocaine is preferred as it provides adequate anesthesia with lower total drug exposure and allows for larger volumes if needed.

Alternative for lidocaine allergy: Use bacteriostatic saline (0.9% benzyl alcohol) or 1% diphenhydramine 1, 8. Bacteriostatic saline showed equivalent pain control to buffered 1% lidocaine in hip injections 8.

Common Pitfall

Do not use lidocaine for intra-articular hip joint infusions - this is associated with chondrolysis and is not FDA-approved 2. The question asks about bursa injection, which is appropriate, but avoid confusion with intra-articular continuous infusions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.